Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 725.37M | 652.52M | 496.25M | 468.72M | 479.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 725.37M | 652.52M | 496.25M | 468.72M | 479.53M |
| Cost of Revenue | 636.95M | 571.68M | 412.47M | 371.47M | 379.76M |
| Gross Profit | 88.42M | 80.84M | 83.77M | 97.25M | 99.77M |
| SG&A Expenses | 68.97M | 67.99M | 72.36M | 61.86M | 75.50M |
| Depreciation & Amortization | 21.49M | 21.57M | 21.56M | 45.04M | 23.62M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 727.41M | 661.24M | 506.38M | 478.36M | 478.88M |
| Operating Income | -2.04M | -8.72M | -10.14M | -9.64M | 658.00K |
| Income Before Tax | -22.45M | -25.65M | -25.72M | -430.81M | -19.96M |
| Income Tax Expenses | 1.12M | 2.72M | 910.00K | -1.68M | 906.00K |
| Earnings from Continuing Operations | -23.57M | -28.36M | -26.63M | -429.13M | -20.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.57M | -28.36M | -26.63M | -429.13M | -20.86M |
| EBIT | -2.04M | -8.72M | -10.14M | -9.64M | 658.00K |
| EBITDA | 13.65M | 7.05M | 5.62M | 29.70M | 18.67M |
| EPS Basic | -0.21 | -0.25 | -0.24 | -3.84 | -0.24 |
| Normalized Basic EPS | -0.10 | -0.14 | -0.14 | -0.16 | -0.08 |
| EPS Diluted | -0.21 | -0.25 | -0.24 | -3.84 | -0.24 |
| Normalized Diluted EPS | -0.10 | -0.14 | -0.14 | -0.16 | -0.08 |
| Average Basic Shares Outstanding | 113.07M | 112.54M | 111.91M | 111.61M | 114.07M |
| Average Diluted Shares Outstanding | 113.07M | 112.54M | 111.91M | 111.61M | 114.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.00% | -9.25% |